Article ID Journal Published Year Pages File Type
8225375 International Journal of Radiation Oncology*Biology*Physics 2012 7 Pages PDF
Abstract
These findings demonstrate for the first time that amifostine is a normal liver radioprotector. They further suggest that it may be useful to combine amifostine with fractionated or stereotactic body radiation therapy for patients with focal intrahepatic cancer.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , , , , , , , , ,